NASHVILLE, TN | August 16, 2022 Originally published on EIN Presswire Today, Inc. revealed that EvidenceCare is No. 1028 on its annual Inc. 5000 list, the most prestigious ranking of…
Spencer HollemanAugust 16, 2022
As an ongoing commitment to improving its clinical platform, EvidenceCare recently formed its first Clinical Advisory Group. The group consists of various clinical and revenue cycle leaders and stakeholders in…
Spencer HollemanJune 13, 2022
The Tech Tribune recently recognized EvidenceCare as a "Best Tech Startup" in Brentwood, TN. The Tech Tribune considered several factors in its selection, including revenue potential, leadership team, brand/product traction,…
Spencer HollemanMay 17, 2022
Nashville, TN, originally published on EIN Presswire, March 14, 2022 EvidenceCare was awarded a second patent for its software, CareGauge, which provides zero-click transparency into care utilization using real-time data…
Spencer HollemanMarch 14, 2022
EvidenceCare and Moffitt Cancer Center Donate Portion of New Product Proceeds to Benefit Scott Hamilton CARES Foundation Thursday, January 6, 2022 | Nashville, TN | EINPresswire.com EvidenceCare’s latest CarePathways product,…
Spencer HollemanJanuary 6, 2022
December 14, 2021 | Nashville, TN EvidenceCare, an EHR-integrated clinical decision support company, today announces its product, CareGauge, as the winner of two 2021 Fierce Healthcare Innovation Awards in the…
Spencer HollemanDecember 14, 2021
“We finally have enough data to make evidence-based recommendations on the best-practice approach to managing these patients in the emergency department.”
Spencer HollemanNovember 30, 2021
Nashville, TN and Seattle, WA I November 15, 2021 EvidenceCare, a Nashville-based clinical decision support software company, is expanding its reach into Seattle, Washington, with the opening of its second…
Spencer HollemanNovember 15, 2021
AVIA recently highlighted EvidenceCare’s partnerships with Bon Secours Mercy Health and Ballad Health facilitated by AVIA’s Venture Network.
Spencer HollemanOctober 20, 2021
